BLAINJECTIONINJECTABLE
Approved
Mar 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
5/8 — Partial
CHORIONIC GONADOTROPIN (chorionic gonadotropin) by Fresenius Kabi is clinical pharmacology: the action of hcg is virtually identical to that of pituitary lh, although hcg appears to have a small degree of fsh activity as well. First approved in 1973.
Drug data last refreshed 13h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Chorionic Gonadotropin (hCG) is a hormone injectable that mimics luteinizing hormone (LH) to stimulate gonadal steroid production in both males and females. It is used to treat infertility, cryptorchidism, and hypogonadism by stimulating testosterone production in men and progesterone in women to support ovulation and early pregnancy. The drug works by binding to LH receptors on Leydig cells in the testis and corpus luteum in the ovary, triggering hormone synthesis essential for reproductive function.
$0.565MPart D
LOE ApproachingProduct is in late-stage lifecycle with minimal Part D utilization (624 claims in 2023), signaling a niche market with small commercial team footprint.
Mechanism of Action
CLINICAL PHARMACOLOGY: The action of HCG is virtually identical to that of pituitary LH, although HCG appears to have a small degree of FSH activity as well. It stimulates production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (5)
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Started Jan 2026
20,000 enrolled
OsteoporosisHypercalcemiaPrimary Hyperparathyroidism+3 more
Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation
Started Nov 2018
26 enrolled
Infertility
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
Started Apr 2016
176 enrolled
Infertility
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
Started Sep 2014
105 enrolled
Infertility
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Started Jan 2012
15 enrolled
Endometrial ThicknessPregnancy Outcome
Worked on CHORIONIC GONADOTROPIN at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.